BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33620560)

  • 21. Comparison of
    Pang Y; Zhao L; Luo Z; Hao B; Wu H; Lin Q; Sun L; Chen H
    Radiology; 2021 Feb; 298(2):393-402. PubMed ID: 33258746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of [
    Zhou Y; Yang X; Liu H; Luo W; Liu H; Lv T; Wang J; Qin J; Ou S; Chen Y
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3493-3501. PubMed ID: 33829416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined Early and Late [
    Hohberg M; Kobe C; Täger P; Hammes J; Schmidt M; Dietlein F; Wild M; Heidenreich A; Drzezga A; Dietlein M
    Mol Imaging Biol; 2019 Jun; 21(3):558-566. PubMed ID: 30105521
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Ding F; Huang C; Liang C; Wang C; Liu J; Tang D
    Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):290-300. PubMed ID: 34181060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a
    Varasteh Z; Mohanta S; Robu S; Braeuer M; Li Y; Omidvari N; Topping G; Sun T; Nekolla SG; Richter A; Weber C; Habenicht A; Haberkorn UA; Weber WA
    J Nucl Med; 2019 Dec; 60(12):1743-1749. PubMed ID: 31405922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A head-to-head comparison of
    Qin C; Liu F; Huang J; Ruan W; Liu Q; Gai Y; Hu F; Jiang D; Hu Y; Yang K; Lan X
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3228-3237. PubMed ID: 33609152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FAPI-74 PET/CT Using Either
    Giesel FL; Adeberg S; Syed M; Lindner T; Jiménez-Franco LD; Mavriopoulou E; Staudinger F; Tonndorf-Martini E; Regnery S; Rieken S; El Shafie R; Röhrich M; Flechsig P; Kluge A; Altmann A; Debus J; Haberkorn U; Kratochwil C
    J Nucl Med; 2021 Feb; 62(2):201-207. PubMed ID: 32591493
    [No Abstract]   [Full Text] [Related]  

  • 28. State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis.
    Sollini M; Kirienko M; Gelardi F; Fiz F; Gozzi N; Chiti A
    Eur J Nucl Med Mol Imaging; 2021 Dec; 48(13):4396-4414. PubMed ID: 34173007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and Development of
    Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
    J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of Forced Diuresis with Additional Late Imaging in
    Alberts I; Niklas-Hünermund J; Sachpekidis C; Zacho HD; Mingels C; Dijkstra L; Bohn KP; Läppchen T; Gourni E; Rominger A; Afshar-Oromieh A
    J Nucl Med; 2021 Sep; 62(9):1252-1257. PubMed ID: 33547214
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Zhao L; Chen S; Chen S; Pang Y; Dai Y; Hu S; Lin L; Fu L; Sun L; Wu H; Chen H; Lin Q
    Radiother Oncol; 2021 May; 158():55-61. PubMed ID: 33621587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of
    Şahin E; Elboğa U; Çelen YZ; Sever ÖN; Çayırlı YB; Çimen U
    Eur J Radiol; 2021 Sep; 142():109867. PubMed ID: 34315086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial Clinical Experience with
    Ferdinandus J; Costa PF; Kessler L; Weber M; Hirmas N; Kostbade K; Bauer S; Schuler M; Ahrens M; Schildhaus HU; Rischpler C; Grafe H; Siveke JT; Herrmann K; Fendler WP; Hamacher R
    J Nucl Med; 2022 May; 63(5):727-734. PubMed ID: 34385340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superiority of
    Elboga U; Sahin E; Kus T; Cayirli YB; Aktas G; Uzun E; Cinkir HY; Teker F; Sever ON; Aytekin A; Yilmaz L; Aytekin A; Cimen U; Mumcu V; Kilbas B; Çelen YZ
    Ann Nucl Med; 2021 Dec; 35(12):1321-1331. PubMed ID: 34436740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standardized uptake values and ratios on 68Ga-DOTATATE PET-computed tomography for normal organs and malignant lesions and their correlation with Krenning score in patients with metastatic neuroendocrine tumors.
    Menon BK; Kalshetty A; Bhattacharjee A; Basu S
    Nucl Med Commun; 2020 Oct; 41(10):1095-1099. PubMed ID: 32732598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of [
    Chen H; Zhao L; Ruan D; Pang Y; Hao B; Dai Y; Wu X; Guo W; Fan C; Wu J; Huang W; Lin Q; Sun L; Wu H
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):73-86. PubMed ID: 32588089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibroblast Activation Protein-Targeted PET/CT with
    Luo Y; Pan Q; Yang H; Peng L; Zhang W; Li F
    J Nucl Med; 2021 Feb; 62(2):266-271. PubMed ID: 32513902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
    Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
    J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.